2026-04-25T13:46:38Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:42295 2024-06-12T14:28:35Z

FRI0143 A radomized, double-blind, phase 3 study demonstrates clinical equivalence od CT-P13 to ifliximab when co-administered with methotrexate in patients with active rheumatoid arthritis /unibl/author/DH Yoo /unibl/author/P Hrycaj /unibl/author/P Miranda /unibl/author/M Piotrowski /unibl/author/S Shevchuk /unibl/author/V Kovalenko /unibl/author/Nenad Prodanović /unibl/author/M Abello-Banfi /unibl/author/S Gutierrez-Ureña /unibl/author/L Morales-Olazabal /unibl/author/M Tee /unibl/author/R Jimenez /unibl/author/O Zamani /unibl/author/SJ Lee /unibl/author/H Kim /unibl/author/W Park /unibl/author/U Müller-Ladner 2014 Academic Article text 10 10 /unibl/sci/idNaucniRad:25136 ANNALS OF THE RHEUMATIC DISEASES 0003-4967 ANNALS OF THE RHEUMATIC DISEASES 0003-4967 D. Yoo, P. Hrycaj, P. Miranda, E. Piotrowski, S. Shevchuk, V. Kovalenko, N. Prodanović, M. Abello-Banfi, S. Gutierrez-Ureña, L. Morales-Olazabal, M. Tee, R. Jimenez, O. Zamani, S. Lee, H. Kim, W. Park, U. Müller-Ladner, FRI0143 A radomized, double-blind, phase 3 study demonstrates clinical equivalence od CT-P13 to ifliximab when co-administered with methotrexate in patients with active rheumatoid arthritis, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2014 https://www.pub.unibl.org/s/cir/item/42295